| 000 | 01526 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512024252.0 | ||
| 264 | 0 | _c19910501 | |
| 008 | 199105s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/BF02125736 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGood, A P | |
| 245 | 0 | 0 |
_aHemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cJan 1988 |
||
| 300 |
_a529-34 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aClonidine _xpharmacology |
| 650 | 0 | 4 |
_aExtremities _xblood supply |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoramin _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xblood supply |
| 650 | 0 | 4 |
_aLiver Circulation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aUnverferth, D V | |
| 700 | 1 | _aLeier, C V | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 1 _gno. 5 _gp. 529-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02125736 _zAvailable from publisher's website |
| 999 |
_c2914558 _d2914558 |
||